Literature DB >> 20064871

The evidence for whole-spine MRI in the assessment of axial spondyloarthropathy.

Alexander N Bennett1, Helena Marzo-Ortega, Amer Rehman, Paul Emery, Dennis McGonagle.   

Abstract

In the past decade, fat-suppression MRI techniques have been increasingly used for the assessment of axial-SpA. Indeed, newly proposed classification criteria have suggested the inclusion of fat-suppression MRI for the evaluation of the SI joint in inflammatory back pain (IBP) of suspected axial-SpA. However, recent data on the whole spine have identified certain MRI spinal lesions to be highly diagnostic of axial-SpA; that the SI joint can be spared in axial-SpA; and that IBP may originate in the lumbar spine rather than SI joint. Therefore, it is proposed that MRI of the whole spine and not just the SI joint should now become a routine part of the assessment of axial-SpA. Not only is spinal MRI of great diagnostic utility in axial-SpA but there is also increasing evidence to suggest that it can play a significant role in the management, in particular directing anti-TNF therapy in AS, and also it may be prognostically useful in axial-SpA. With the wider availability, improving technology and falling cost of MRI, and the difficulty that clinical assessment of axial-SpA poses, especially in early disease, there is now a strong case for the use of whole-spine MRI in the diagnosis and management of axial-SpA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20064871     DOI: 10.1093/rheumatology/kep427

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  4 in total

Review 1.  Early axial spondyloarthritis.

Authors:  Robert A Colbert
Journal:  Curr Opin Rheumatol       Date:  2010-09       Impact factor: 5.006

2.  Diagnosis and treatment of enthesitis-related arthritis.

Authors:  Pamela F Weiss
Journal:  Adolesc Health Med Ther       Date:  2012-06

3.  A quick decrease of bone marrow edema in sacroiliac joint could be served as a novel marker for dose tapering of etanercept in ankylosing spondylitis patients.

Authors:  Ruishan Yang; Hongda Liu; Mengpo Fan
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

Review 4.  Fibrosis imaging: Current concepts and future directions.

Authors:  Maike Baues; Anshuman Dasgupta; Josef Ehling; Jai Prakash; Peter Boor; Frank Tacke; Fabian Kiessling; Twan Lammers
Journal:  Adv Drug Deliv Rev       Date:  2017-11-20       Impact factor: 15.470

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.